Previous 10 | Next 10 |
No limit to number of fragments included in the pools Optimized chemistry enables direct synthesis of up to 500 bp double stranded fragments Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA usin...
2024-05-10 06:00:00 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Genomics is the future of medicine. With it, companies are racing to shed light on human health and disease. Over the last two decades, related studies have allowed us to create genetic risk sc...
As required by the rules of the Nasdaq Stock Market, Twist Bioscience Corporation (NASDAQ: TWST) (“Twist” or the “Company”), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that it h...
2024-05-03 13:32:54 ET Summary Market conditions remain tough for biotech companies, but Twist continues to perform well compared to peers. Twist Bioscience's second quarter results were strong, driven by NGS demand, and the company expects this strength to continue. Twist's v...
A look at the top 10 most actives in the United States Jaguar Health Inc. (JAGX) rose 11.6% to $0.3271 on volume of 42,007,446 shares Vaxxinity Inc. (VAXX) rose 30.5% to $0.136 on volume of 33,389,450 shares Apple Inc. (AAPL) rose 6.3% to $184.01 on volume of 31,437,720 shares PROSHARES...
2024-05-03 07:00:08 ET Catherine Ramsey Schulte from Robert W. Baird issued a price target of $40.00 for TWST on 2024-05-03 06:27:00. The adjusted price target was set to $40.00. At the time of the announcement, TWST was trading at $32.01. The overall price target consen...
2024-05-02 22:54:08 ET Twist Bioscience Corporation (TWST) Q2 2024 Earnings Conference Call May 2, 2024 16:30 ET Company Participants Angela Bitting - Senior Vice President, Corporate Affairs Emily Leproust - Chief Executive Officer & Co-Founder Adam Laponis ...
2024-05-02 17:21:44 ET More on Twist Bioscience Twist Bioscience: A 'Hold' In DNA Data Storage Twist Bioscience: Strong Performance In A Soft Market Twist Bioscience Q2 2024 Earnings Preview Seeking Alpha’s Quant Rating on Twist Bioscience Hist...
2024-05-02 16:06:36 ET More on Twist Bioscience Twist Bioscience: A 'Hold' In DNA Data Storage Twist Bioscience: Strong Performance In A Soft Market Twist Bioscience Q2 2024 Earnings Preview Seeking Alpha’s Quant Rating on Twist Bioscience Hist...
– Record revenue of $75.3M in 2QFY24, an increase of 25% over $60.2M in 2QFY23 – – Orders increased to $93.2M in 2QFY24, growth of 45% over $64.2M in 2QFY23 – — Increased FY 2024 revenue guidance to a range of $300M to $304M; Increased FY 2024 gross marg...
News, Short Squeeze, Breakout and More Instantly...
Twist Bioscience Corporation Company Name:
TWST Stock Symbol:
NASDAQ Market:
Twist Bioscience Corporation Website:
2024-06-28 07:15:04 ET Barclays analyst issues OVERWEIGHT recommendation for TWST on June 28, 2024 05:29AM ET. The previous analyst recommendation was Overweight. TWST was trading at $47.48 at issue of the analyst recommendation. The overall analyst consensus : BUY. ...
TB206-001 shown to be a high-affinity, cross-reactive humanized antibody antagonist of A 2A R with in vivo tumor suppressing activity TB206-001 available for out-licensing Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering...
Twist Bioscience Corporation (NASDAQ: TWST) has caught the attention of the investment community today with its bullish price action. The company's shares have moved 11.58% on the day to $52.42. Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-bas...